Summary
-
1.
The effects of FLA-136 [4-amino-3-(2,6-dichlorobenzylidenehydrazino)-1,2,4-triazol] on blood pressure and heart rate in anaesthetized, normotensive rats, stimulation-induced tachycardia in pithed rats and sedation in mice were studied.
-
2.
Following intravenous administration to anaesthetized normotensive rats FLA-136 caused a dose-dependent decrease in mean arterial pressure accompanied by a reduction in cardiac frequency. Both actions showed a slow onset and maximal effects were reached about 1 h after application. Yohimbine and piperoxan almost completely inhibited these haemodynamic effects of FLA-136, whereas prazosin was ineffective. The efficacy of FLA-136 in reducing blood pressure and heart rate was partly impaired after pretreatment with reserpine (5 mg/kg), and totally abolished in animals which had received this reserpine treatment twice and α-methyl-p-tyrosine methylester.
-
3.
FLA-136 neither displayed an acute effect on the stimulation-induced tachycardia nor affected the clonidine-induced reduction of the elevated heart rate in pithed rats. In contrast, the cardiac, responses to stimulation were dose-dependently diminished after pretreatment with FLA-136. At high doses FLA-136 moderately decreased the hypertensive effect of clonidine.
-
4.
FLA-136 dose-dependently prolonged the hexobarbitone (75 mg/kg) induced loss of the righting reflex in mice. This action of FLA-136 was antagonized by previous pretreatment with yohimbine and piperoxan, whereas mianserin was less effective. Prazosin tended to increase the sedative effect of FLA-136.
-
5.
The results suggest the involvement of presynaptic α-adrenoceptors in the cardiovascular and sedative properties of FLA-136. These effects, however, may not be caused by FLA-136 itself, but are possibly mediated by one more active metabolites.
Similar content being viewed by others
References
Andén, N.-E., Grabowska, M.: FLA-136: Selective agonist at central alpha-adrenoreceptors mediating changes in the turnover of noradrenaline. Naunyn-Schmiedeberg's Arch. Pharmacol. 298, 239–243 (1977)
Andén, N.-E., Corrodi, H., Fuxe, K., Hökfelt, B., Hökfelt, T., Rydin, C. Svensson, T.: Evidence for a central noradrenaline receptor stimulation by clonidine. Life Sci., 9 (1), 513–523 (1970)
Andén, N.-E., Grabowska, M., Strömbom, U.: Different alphaadrenoreceptors in the central nervous system mediating biochemical and functional effects of clonidine and receptor blocking agents. Naunyn-Schmiedeberg's Arch. Pharmacol. 292, 43–52 (1976)
Baumann, P. A. Maître, L.: Blockade of presynaptic α-receptors in the rat cortex by antidepressants. Experientia 31, 726 (1975)
Borowski, E., Ehrl, H., Starke, K.: Relative pre-and postsynaptic potencies of α-adrenolytic drugs. Naunyn-Schmiedeberg's Arch. Pharmacol. 293, R2 (1976)
Cambridge, D., Davey, M. J., Massingham, R. Prazosin: A selective antagonist of postsynaptic α-adrenoceptors. Br. J. Pharmacol. 59, 514P-515P (1977)
Cavero, I., Lefèvre, F., Roach, A. G.: Differential effects of prazosin on the pre-and postsynaptic α-adrenoceptors in the rat and dog. Br. J. Pharmacol. 61, 469P (1977)
Cavero, I., Roach, A. G.: The effect of prazosin on the clonidine-induced hypotension and bradycardia in rats and sedation in chicks. Br. J. Pharmacol. 62, 468P-469P (1978)
Delbarre, B., Schmitt, H.: A further attempt to characterize sedative receptors activated by clonidine in chickens and mice. Eur. J. Pharmacol. 22, 355–359 (1973)
Dollery, C. T., Davies, D. S., Draffan, G. H., Dargie, H. J., Dean, C. R., Reid, J. L., Clare, R. A., Murray, S.: Clinical pharmacology and pharmacokinetics of clonidine. Clin. Pharmacol. Therap. 19 11–17 (1976)
Doxey, J. C., Easingwood, R. E.: Profiles of α-adrenoceptor antagonists in the pithed rat. Br. J. Pharmacol. 63, 401P-402P (1978)
Doxey, J. C., Smith, C. F. C., Walker, J. M.: Selectivity of blocking agents for pre-and postsynaptic α-adrenoceptors. Br. J. Pharmacol. 60, 91–96 (1977)
Drew, G. M.: Effects of α-adrenoceptor agonists and antagonists on pre-and postsynaptically located α-adrenoceptors. Eur. J. Pharmacol. 36, 313–320 (1976)
Drew, G. M., Gower, A. J., Marriot, A. S.: Pharmacological characterization of α-adrenoceptors which mediate clonidine-induced sedation. Br. J. Pharmacol. 61, 468P (1977)
Erikson, H. E., Florvall, L. G.: The preparation and antihypertensive activity of 4-amino-3-(2,6-dichlorobenzylidenehydrazino)-1,2,4-triazol and some related compounds. Acta Pharmaceut. Suec. 13, 79–96 (1976)
Farnebo, L.-O., Hamberger, B.: Drug-induced changes in the release of 3H-monoamines from field stimulated rat brain slices. Acta Physiol. Scand., Suppl. 371, 35–44 (1971)
Haeusler, G.: Clonidine-induced inhibition of sympathetic nerve activity: No indication for a central presynaptic or an indirect sympathomimetic mode of action. Naunyn-Schmiedeberg's Arch. Pharmacol. 286, 97–111 (1974)
Hoefke, W., Kobinger, W.: Pharmakologische Wirkungen des 2-(2,6-Dichlorphenylamino)-2-imidazolin-hydrochlorids, einer neuen, antihypertensiven Substanz. Arzneim.-Forsch. 16, 1038–1058 (1966)
Kobinger, W.: Central α-adrenergic systems as targets for hypotensive drugs. Rev. Physiol. Biochem. Pharmacol. 81, 39–100 (1978)
Kobinger, W., Pichler, L.: Centrally induced reduction in sympathetic tone, a postsynaptic α-adrenoceptor-stimulating action of imidazolines. Eur. J. Pharmacol. 40, 311–320 (1976)
Robson, R. D., Antonaccio, M. J., Saelens, J. K., Liebman, J.: Antagonism by mianserin and classical α-adrenoceptor blocking drugs of some cardiovascular and behavioral effects of clonidine. Eur. J. Pharmacol. 47, 431–442 (1978)
Starke, K., Montel, H.: Involvement of α-receptors in clonidine-induced inhibition of transmitter release from central monoamine neurons. Neuropharmacology 12, 1073–1080 (1973)
Starke, K., Endo, T., Taube, H. D.: Relative pre-and postsynaptic potencies of α-adrenoceptor agonists in the rabbit pulmonary artery. Naunyn-Schmiedeberg's Arch. Pharmacol. 291, 55–78 (1975a)
Starke, K., Borowski, E., Endo, T.: Preferential blockade of presynaptic α-adrenoceptors by yohimbine. Eur. J. Pharmacol. 34, 385–388 (1975b)
Timmermans, P. B. M. W. M., van Zwieten, P. A.: Central and peripheral effects of some imidazolidines. Eur. J. Pharmacol. 45, 229–336 (1977a)
Timmermans, P. B. M. W. M., van Zwieten, P. A.: Hypotensive and bradycardic activities of clonidine and related imidazolidines; structure-activity relationship. Arch. Int. Pharmacodyn. Ther. 228, 237–250 (1977b)
Timmermans, P. B. M. W. M., Lam, E., van Zwieten, P. A.: The interaction between prazosin and clonidine at α-adrenoceptors in rats and cats. Eur. J. Pharmacol. (in press 1979)
Warnke, E., Hoefke, W.: Influence of central pretreatment with 6-hydroxydopamine on the hypotensive effect of clonidine. Arzneim.-Forsch. 27, 2311–2313 (1977)
Zebrowska-Lupina, I., Przegalinski, E., Sloniec, M., Kleinrock, Z.: Clonidine-induced locomotor hyperactivity in rats. The role of central postsynaptic α-adrenoceptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 297, 227–231 (1977)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Timmermans, P.B.M.W.M., Lam, E. & van Zwieten, P.A. Involvement of presynaptic alpha-adrenoceptors in the cardiovascular and sedative effects of FLA-136. Naunyn-Schmiedeberg's Arch. Pharmacol. 306, 127–134 (1979). https://doi.org/10.1007/BF00498982
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00498982